Rostami-Nejad Mohammad, Razzaghi Zahra, Esmaeili Somayeh, Rezaei-Tavirani Sina, Akbarzadeh Baghban Alireza, Vafaee Reza
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2020 Spring;13(2):155-160.
To assess the immunological reactions and gene expression level in the celiac disease (CD) patients under a gluten-free diet (GFD).
CD is an autoimmune disorder in genetic susceptible individuals and lifelong gluten free diet is the effective treatment method. It seems that treated patients will experience a normal life style though there are documents about some potential damages.
Gene expression profiles of treated CD patients and healthy samples were obtained from Gene Expression Omnibus (GEO) and compared to find the differentially expressed genes (DEGs). The identified DEGs were introduced in the network and gene ontology (GO) analysis.
Ten differentially expressed genes (DEGs) including CCR2, IRF4, FASLG, CCR4, ICOS, TNFSF18, BACH2, LTF, PRM1, and PRM2 were investigated via network analysis. Seven clusters of biological processes (BP) were determined as the affected BP. PThe finding led to introduction of CCR2, IRF4, FASLG, CCR4, and ICOS as the potential immunological markers that are still active despite GFD in the treated CD patients.
The results of this study indicated that the immune system is already active in treated CD patients despite GFD treatment and exposure to gluten causes potential immunological reactions in these patients.
评估乳糜泻(CD)患者在无麸质饮食(GFD)下的免疫反应和基因表达水平。
CD是遗传易感个体中的一种自身免疫性疾病,终身无麸质饮食是有效的治疗方法。尽管有文献报道了一些潜在损害,但接受治疗的患者似乎将经历正常的生活方式。
从基因表达综合数据库(GEO)中获取接受治疗的CD患者和健康样本的基因表达谱,并进行比较以发现差异表达基因(DEG)。将鉴定出的DEG引入网络和基因本体(GO)分析。
通过网络分析研究了包括CCR2、IRF4、FASLG、CCR4、ICOS、TNFSF18、BACH2、LTF、PRM1和PRM2在内的10个差异表达基因(DEG)。确定了7个生物过程(BP)簇为受影响的BP。这一发现导致将CCR2、IRF4、FASLG、CCR4和ICOS确定为潜在的免疫标志物,尽管接受治疗的CD患者采用了GFD,但这些标志物仍然活跃。
本研究结果表明,尽管采用了GFD治疗,但接受治疗的CD患者的免疫系统已经活跃,接触麸质会在这些患者中引起潜在的免疫反应。